David M. Spencer
No más puestos en curso
Historial de carrera de David M. Spencer
Antiguos cargos conocidos de David M. Spencer.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 14/07/2004 | 01/03/2019 |
| Fundador | 14/07/2004 | 01/03/2019 | |
| KIROMIC BIOPHARMA, INC. | Director/Miembro de la Junta | 01/10/2019 | - |
| Director Técnico/Científico/I+D | 01/10/2019 | - | |
| Baylor College of Medicine | Corporate Officer/Principal | - | - |
Formación de David M. Spencer.
| Massachusetts Institute of Technology | Doctorate Degree |
| University of California San Diego | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| KIROMIC BIOPHARMA, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
- Bolsa de valores
- Insiders
- David M. Spencer
- Experiencia